Gross, P., J.H.U.Brown, M.L.Westrick, R.P.Srsic, N.L.Butler, and T.F.Hatch. 1955a. Toxicologic study of calcium halophosphate phosphors and antimony trioxide. I. Acute and chronic toxicity and some pharmacologic aspects. Arch. Ind. Health 11:473–478.

Gross, P., M.L.Westrick, J.H.U.Brown, R.P.Srsic, H.H.Schrenk, and T.F.Hatch. 1955b. Toxicologic study of calcium halophosphate phosphors and antimony trioxide. II. Pulmonary studies. Arch. Ind. Health 11:479–486.

Groth, D.H., L.E.Stettler, J.R.Burg, W.M.Busey, G.C.Grant, and L.Wong. 1986. Carcinogenic effects of antimony trioxide and antimony ore concentrate in rats. J. Toxicol. Environ. Health 18(4):607–26.

Gurnani, N., A.Sharma, and G.Talukder. 1992. Comparison of the clastogenic effects of antimony trioxide on mice in vivo following acute and chronic exposure. Bio-Metals 5(1):47–50.

Haskell Laboratory (Haskell Laboratory for Toxicology and Industrial Medicine). 1970a. Primary Skin Irritation and Sensitization Tests in Guinea Pigs. U.S. EPA OTS document ID# 878220294.

Haskell Laboratory (Haskell Laboratory for Toxicology and Industrial Medicine). 1970b. Primary Skin Irritation and Sensitization Tests. U.S. EPA OTS document ID# 878220307.

Hatlelid, K. 1999. Toxicity Review for Calcium Molybdate and Zinc Molybdate. Memorandum, dated March 2, 1999, from Kristina Hatlelid, Toxicologist, Division of Health Sciences, to Ronald Medford, Assistant Executive Director for Hazard Identification and Reduction, U.S. Consumer Product Safety Commission, Washington, DC.

Hext, P.M., P.J.Pinto, and B.A.Rimmel. 1999. Subchronic feeding study of antimony trioxide in rats. J. Appl. Toxicol. 19(3):205–209.

Hiraoka, N. 1986. The toxicity and organ distribution of antimony after chronic administration to rats. J. Kyoto Prefect Univ. Med. 95:997–1017.

IARC (International Agency for Research on Cancer). 1989. Antimony trioxide and antimony trisulfide. Pp. 291–305 in IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 47, Some Organic Solvents, Resin Monomers and Related Compounds, Pigments and Occupational Exposures in Paint Manufacture and Painting. Lyon, France: World Health Organization, International Agency for Research on Cancer.

ICRP (International Commission on Radiological Protection). 1981. Metabolic data for antimony. Pp. 46–49 in Radiation Protection, ICRP Publication 30, Part 3, Including Addendum to Parts 1 and 2, Limits for Intakes of Radionuclides by Workers. International Commission on Radiological Protection. Elmsford, N.Y.: Pergamon Press.

Industrial Bio-Test Laboratories, Inc. 1973. Human Repeated Insult Patch Test with TS-162. U.S. EPA OTS document I.D.# 878211206.

James, L.F., V.A.Lazar, and W.Binns. 1966. Effects of sublethal doses of certain minerals on pregnant ewes and fetal development. Am. J. Vet. Res. 27(116): 132–135.

Front Matter (R1-R22)

Executive Summary (1-14)

1 Introduction (15-20)

2 Assessment of Health Risks from the Use of Flame Retardants (21-34)

3 Exposure Assessment Methodology (35-52)

4 Hexabromocyclododecane (53-71)

5 Decabromodiphenyl Oxide (72-98)

6 Alumina Trihydrate (99-130)

7 Magnesium Hydroxide (131-148)

8 Zinc Borate (149-191)

9 Calcium and Zinc Molybdates (192-228)

10 Antimony Trioxide (229-261)

11 Antimony Pentoxide and Sodium Antimonate (262-272)

12 Ammonium Polyphosphates (273-290)

13 Phosphonic Acid, (3-{[Hydroxymethyl]amino}-3-Oxopropyl)-Dimethyl Ester (291-306)

14 Organic Phosphonates (307-337)

15 Tris Monochloropropyl Phosphates (338-357)

16 Tris (1,3-dichloropropyl-2) Phosphate (358-386)

17 Aromatic Phosphate Plasticizers (387-416)

18 Tetrakis(hydroxymethyl) Phosphonium Salts (417-439)

19 Chlorinated Paraffins (440-492)

Appendix A Biographical Sketches (493-498)

Appendix B Flame-Retardant Composition in Fabrics: Their Durability and Permanence (499-512)